These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39207088)

  • 1. The current role of adjuvant radiotherapy in management of medullary thyroid carcinoma: A single institute analysis.
    Bhuvana J; Shivhare V; Rath S; Parikh A; Kunikullaya US
    J Cancer Res Ther; 2024 Aug; ():. PubMed ID: 39207088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
    Jin M; Megwalu UC; Noel JE
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
    Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
    Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].
    Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P
    Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant external beam radiation for medullary thyroid carcinoma.
    Martinez SR; Beal SH; Chen A; Chen SL; Schneider PD
    J Surg Oncol; 2010 Aug; 102(2):175-8. PubMed ID: 20648590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience.
    Call JA; Caudill JS; McIver B; Foote RL
    Rare Tumors; 2013; 5(3):e37. PubMed ID: 24179649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer.
    Kwon J; Wu HG; Youn YK; Lee KE; Kim KH; Park DJ
    Radiat Oncol J; 2013 Sep; 31(3):162-70. PubMed ID: 24137562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute.
    Esmati E; Aleyasin A; Ghalehtaki R; Jafari F; Farhan F; Aghili M; Haddad P; Kazemian A
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1652. PubMed ID: 35691611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter.
    Zhang Q; Fu S; Liu T; Peng L; Huang G; Lu JJ
    Urol Oncol; 2009; 27(1):14-20. PubMed ID: 18367127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
    Hurmuz P; Ozyigit G; Kilickap S; Esen CSB; Akdogan B; Ozen H; Akyol F
    Urol Oncol; 2021 Jun; 39(6):368.e19-368.e29. PubMed ID: 33189528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
    Panigrahi B; Roman SA; Sosa JA
    Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
    Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment outcomes after adjuvant radiotherapy following surgery for patients with stage I endometrial cancer.
    Kim J; Lee KJ; Park KR; Ha B; Kim YJ; Jung W; Lee R; Kim SC; Moon HS; Ju W; Kim YH; Lee J
    Radiat Oncol J; 2016 Dec; 34(4):265-272. PubMed ID: 27703126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
    Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
    Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.